ClinicalTrials.govpublic full text
Safety of LBH589 Alone and in Combination With IV Docetaxel and Prednisone
hormone refractory prostate cancer, lbh589, prostate cancer, hrpc, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 827876
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.